𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined treatment of Dunning R3327 rat prostatic tumor with the 5α-reductase inhibitor PNU 157706 and the antiandrogen bicalutamide

✍ Scribed by Tiziana Zaccheo; Donata Giudici; Achille Panzeri; Enrico di Salle

Book ID
105744785
Publisher
Springer
Year
2000
Tongue
English
Weight
175 KB
Volume
45
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of turosteride, a 5α-reductase in
Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma
✍ Zaccheo, T.; Giudici, D.; di Salle, E. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

BACKGROUND. Turosteride (FCE 26073) is a new, potent, and selective 5␣-reductase inhibitor. We have investigated its effect on tumor growth, organ weight, and serum hormone levels in rats bearing the androgen sensitive Dunning R3327 prostatic carcinoma. METHODS. Animals with tumor diameters of 0.5-1

Effect of early treatment of prostate ca
Effect of early treatment of prostate cancer with the 5α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in rats
✍ Zaccheo, Tiziana; Giudici, Donata; di Salle, Enrico 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

## Background: Turosteride, a selective 5alpha-reductase inhibitor, was reported to be effective in inhibiting the growth of established tumors in the dunning r3327 rat prostatic carcinoma model. we evaluated the preventive effect of turosteride when administered during the latency period in this p